170 related articles for article (PubMed ID: 9560058)
1. Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer.
Caldes T; Iniesta P; Vega FJ; de Juan C; Lopez JA; Diaz-Rubio E; Fernandez C; Cerdan J; Balibrea JL; Benito M
Oncology; 1998; 55(3):249-57. PubMed ID: 9560058
[TBL] [Abstract][Full Text] [Related]
2. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
[TBL] [Abstract][Full Text] [Related]
3. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
4. p53 Mutations are present in colorectal cancer with cytoplasmic p53 accumulation.
Jansson A; Gentile M; Sun XF
Int J Cancer; 2001 May; 92(3):338-41. PubMed ID: 11291068
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.
Incognito LS; Cazares LH; Schellhammer PF; Kuban DA; Van Dyk EO; Moriarty RP; Wright GL; Somers KD
Int J Oncol; 2000 Oct; 17(4):761-9. PubMed ID: 10995889
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.
Bosari S; Viale G; Roncalli M; Graziani D; Borsani G; Lee AK; Coggi G
Am J Pathol; 1995 Sep; 147(3):790-8. PubMed ID: 7677190
[TBL] [Abstract][Full Text] [Related]
7. Association of p53 mutations with short survival in colorectal cancer.
Hamelin R; Laurent-Puig P; Olschwang S; Jego N; Asselain B; Remvikos Y; Girodet J; Salmon RJ; Thomas G
Gastroenterology; 1994 Jan; 106(1):42-8. PubMed ID: 8276207
[TBL] [Abstract][Full Text] [Related]
8. p53 mutation found to be a significant prognostic indicator in distal colorectal cancer.
Okubo R; Masuda H; Nemoto N
Oncol Rep; 2001; 8(3):509-14. PubMed ID: 11295071
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p53 genetic changes in colorectal cancer.
Kressner U; Inganäs M; Byding S; Blikstad I; Påhlman L; Glimelius B; Lindmark G
J Clin Oncol; 1999 Feb; 17(2):593-9. PubMed ID: 10080604
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
Smith DR; Ji CY; Goh HS
Br J Cancer; 1996 Jul; 74(2):216-23. PubMed ID: 8688324
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis.
Leahy DT; Salman R; Mulcahy H; Sheahan K; O'Donoghue DP; Parfrey NA
J Pathol; 1996 Dec; 180(4):364-70. PubMed ID: 9014855
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
14. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.
Reles A; Wen WH; Schmider A; Gee C; Runnebaum IB; Kilian U; Jones LA; El-Naggar A; Minguillon C; Schönborn I; Reich O; Kreienberg R; Lichtenegger W; Press MF
Clin Cancer Res; 2001 Oct; 7(10):2984-97. PubMed ID: 11595686
[TBL] [Abstract][Full Text] [Related]
15. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
16. Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma.
Visscher DW; Sarkar FH; Shimoyama RK; Crissman JD
Diagn Mol Pathol; 1996 Sep; 5(3):187-93. PubMed ID: 8866232
[TBL] [Abstract][Full Text] [Related]
17. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
[TBL] [Abstract][Full Text] [Related]
18. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.
Kern A; Taubert H; Scheele J; Rudroff C; Mothes H; Kappler M; Bartel F; Richter KK
Int J Oncol; 2002 Aug; 21(2):243-9. PubMed ID: 12118317
[TBL] [Abstract][Full Text] [Related]
19. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk J; Thor AD; Beauchamp R; Merritt V; Edgerton SM; Bell DA; Yandell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4961-5. PubMed ID: 8506342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
